RIP1 is a serine/threonine kinase, which is involved in apoptosis and necroptosis. In apoptosis, caspase-8 and FADD have an important role. On the other hand, RIP3 is a key molecule in necroptosis. Recently, we reported that eleostearic acid (ESA) elicits caspase-3-and PARP-1-independent cell death, although ESA-treated cells mediate typical apoptotic morphology such as chromatin condensation, plasma membrane blebbing and apoptotic body formation. The activation of caspases, Bax and PARP-1, the cleavage of AIF and the phosphorylation of histone H2AX, all of which are characteristics of typical apoptosis, do not occur in ESA-treated cells. However, the underlying mechanism remains unclear. To clarify the signaling pathways in ESA-mediated apoptosis, we investigated the functions of RIP1, MEK, ERK, as well as AIF. Using an extensive study based on molecular biology, we identified the alternative role of RIP1 in ESA-mediated apoptosis. ESA mediates RIP1-dependent apoptosis in a kinase independent manner. ESA activates serine/threonine phosphatases such as calcineurin, which induces RIP1 dephosphorylation, thereby ERK pathway is activated. Consequently, localization of AIF and ERK in the nucleus, ROS generation and ATP reduction in mitochondria are induced to disrupt mitochondrial cristae, which leads to cell death. Necrostatin (Nec)-1 blocked MEK/ERK phosphorylation and ESA-mediated apoptosis. Nec-1 inactive form (Nec1i) also impaired ESA-mediated apoptosis. Nec1 blocked the interaction of MEK with ERK upon ESA stimulation. Together, these findings provide a new finding that ERK and kinase-independent RIP1 proteins are implicated in atypical ESA-mediated apoptosis.
Subject Category: Neuroscience
Apoptosis has an important role in the normal development of multicellular eukaryotes and maintenance of adult organism homeostasis. Apoptotic cell death can be induced by two distinct pathways: intrinsic and extrinsic. In the extrinsic pathway, cell death begins with the binding of an appropriate ligand to death receptors, such as tumor necrosis factor (TNF) receptors on the cell surface, and then caspases are activated including caspase-8 and caspase-3.
1-3 However, caspases are not always involved in the cell death in the intrinsic pathway. 4 Programmed necrotic cell death or necroptosis, rather than accidental death (classic necrosis), has been characterized. 1, [5] [6] [7] Necroptosis is a notable example of non-apoptotic cell death when cells are stimulated with TNF-a. Molecules that regulate necroptosis include receptorinteracting protein 1 (RIP1), RIP3, caspase inhibitors such as z-VAD-fmk and reactive oxygen species (ROS). 5, [8] [9] [10] [11] [12] At least RIP3 is considered indispensable for necroptosis.
9,10,13 RIP3 regulates energy metabolism. 8 Both mixed lineage kinase domain-like protein (MLKL) and mitochondrial phosphatase PGAM5 function downstream of RIP3. 14, 15 However, the underlying mechanisms still remain unclear. In contrast, RIP1 is involved in both apoptosis and necroptosis. In RIP1-dependent apoptosis, complex IIb, which includes RIP1, FADD and caspase-8, has a significant role in response to TNF stimulation or loss of IAP. 2, 3, 6, 16 This complex activates caspase cascade to mediate apoptosis. Intermediate domain of RIP1 is required for activation of TNF-a receptor signaling event. 17 The domain determines switch between necroptosis and apoptosis. Like RIP3, the role of RIP1 in cell death remains to be defined. Specificity of necroptosis inhibitors has been reported. [18] [19] [20] Nec1 blocks both RIP1 and indoleamine-2,3-dioxygenase (IDO). Nec1 and Nec1i inhibited IDO. IDO inhibition appears not to be involved in cell death. Nec1i at higher concentrations inhibited necroptosis in mouse L929 cells, suggesting that Nec1i may target molecules other than RIP1. RIP1 is essential for TNF-a signaling to mitogen-activated protein kinase (MAPK). 21 The mechanism by which RIP1 initiates MAPK activation is unclear. The kinase activity of RIP1 does not appear to be required for MAPK activation. 22, 23 Mice lacking RIP1 causes postnatal death. 24 RIP1 is involved in both life and death. Interestingly, RIP3 expression in human and mouse brain tissues was reported to be low. 25, 26 We previously found that a-eleostearic acids (ESA), a conjugated tri-enoic fatty acid, obtained by in vitro screening from Pleurocybella porrigens mushrooms, exert a novel type of programmed cell death, which is AIF-dependent. 27 Since then, we have been interested in this fatty acid because the ingestion of P. porrigens mushrooms led to an outbreak of convulsive encephalopathy in patients with a history of chronic renal failure, resulting in 19 deaths in Japan. Death rates reached up to 32%. A cytotoxic fatty acid (IC 50 ¼ 46.5 mg/ml in B16F1 cells) and unusual amino acids (toxicity in glial cells at several tens of mg/ml) have been isolated from these mushrooms by other groups. [28] [29] [30] Although, many researchers tried to find a causative substance related to the encephalopathy, no evidence has been found so far. In addition, ESA-mediated apoptosis appears to be a novel type of ERK1/2-and RIP1-dependent cell death. We isolated several fatty acids that exert cell cytotoxicity as well as ESA. 31, 32 The relationship between cytotoxic fatty acids and acute encephalopathy caused by ESA remains to be solved. As previously reported, 27 as low as 2 mg/ml ESA induces atypical apoptotic cell death, which is blocked by a-tocopherol (Toc), the MEK inhibitor U0126 and MEK1/2 knockdown. ESA induces caspase-and poly(ADP-ribose) polymerase-1 (PARP-1)-independent cell death associated with the membrane blebbing, cell shrinkage, translocation of AIF and the formation of apoptotic bodies. ESA appears to activate a novel cell death pathway. However, the underlying mechanisms remain to be solved. In this study, we investigated ROS generation, the phosphorylation status of AIF, RIP1 and ERK1/2, and the effect of RIP1 inhibitors such as necrostatin-1 (Nec1), Nec1 inactive control (Nec1i) and Nec5 on ESAmediated apoptosis. The generation of ROS in mitochondria, the mitochondrial membrane potential, the intracellular level of GSH, and the effect of several antioxidants on ESA-mediated apoptosis were also investigated to clarify the mechanisms.
Here, we show that a novel RIP1-dependent apoptotic cell death induced by ESA is mediated through MEK/ERK pathway. ESA-mediated apoptosis is associated with the decrease in phosphorylation of AIF and RIP1, the nuclear translocation of AIF and ERK1/2, and ROS production. ROS generation in mitochondria results in the disruption of mitochondrial cristae structure, leading to cell death.
Results
AIF/RIP1-dependent but RIP3-independent cell death is induced by ESA. ESA elicited apoptotic cell death as shown by membrane blebbing and apoptotic body formation, chromatin condensation, and cell shrinkage in neuronal PC12, SH-SY5Y and NG108-15 cells, as well as rat primary neurons and FBD-102b oligodendrocytes ( Figure 1a ). As reported, ESA-mediated apoptosis is neither caspase-3-dependent nor PARP-1-dependent. 27 Bax is not translocated to mitochondria upon ESA stimulation. ESAmediated apoptosis is AIF-dependent, which is translocated to the nucleus upon ESA stimulation. However, the underlying mechanisms remain unclear. To better understand the mechanisms, the effect of antioxidants, anti-apoptotic Bcl-2 proteins, Bcl-2 and Bcl-X L on ESA-mediated apoptosis was examined. Rat cortical neurons cultured in B27-supplemented media survived, whereas the cells in the media lacking Toc and other antioxidants (B27-AO) were killed by ESA. Dendrites were disrupted in ESA-treated cells. This indicates that antioxidants are effective in preventing ESA-mediated apoptosis (Figure 1b) . Either Bcl-2 or Bcl-X L , or the combination of both proteins had no inhibitory effect on ESA-mediated apoptosis. In contrast, knockdown of AIF and RIP1 blocked ESA-mediated apoptosis. RIP1 as well as AIF has an important role in ESA-mediated apoptosis. Synergistic effect of siRNAs between AIF and RIP1 against ESA-mediated apoptosis was not observed, suggesting that AIF and RIP1 function in the same pathway ( Figure 1c ). RIP3 knockdown did not show any protective effect, indicating that RIP3 is not involved in ESA-mediated apoptosis. Immunoblotting data revealed that a significant amount of RIP3 was not expressed in PC12 cells. RIP3 might not be important in neuronal cells. The necroptosis inhibitor necrostatin-1 (Nec1) and its inactive control (Nec1i) blocked ESA-mediated apoptosis, whereas Nec5 had no effect (Figure 1d ).
ESA mediates ROS generation in mitochondria, which is scavenged by antioxidants. ROS was generated in PC12 and FBD-102b cells when these cells were stimulated with ESA for several hours. To estimate the amount of ROS generated by ESA, we used two fluorescent probes, MitoSOX for detecting mitochondrial superoxides, and BESSo for intracellular superoxides. ESA triggered a small amount of ROS production in mitochondria and intracellular space (Figure 2a , left panel). The amount was much lower than that in activated macrophage. We could detect a small amount of ROS generation because the basal ROS generation in PC12 cells was extremely low. A larger amount of ROS was produced in FBD-102b oligodendrocytes several hours after ESA stimulation as compared with PC12 ( Figure 2a , right panel). Toc and its derivative tocotrienol effectively suppressed both ROS generation (Supplementary Figure 1) and ESA-mediated apoptosis at a physiological concentration (o0.2 mg/ml) (Figure 2b ). Acetylated form of Toc (Toc-Ac) did not effectively block ESA-mediated apoptosis. The apoptosis was also inhibited by antioxidants, such as quercetin, EGCG, sesaminol and NAC at higher concentrations ( Figure 2c ). Grape seed procyanidins (GSP, polymerized catechins), which are not membranepermeable due to numerous hydroxyl groups and its molecular size, had no effect on protecting ESA-mediated apoptosis.
These results suggest that phenolic hydroxyl groups in hydrophobic inhibitors were essential for preventing ESA-mediated apoptosis. The MEK inhibitor U0126 also reduced ESA-triggered ROS generation (Figure 2a ). This suggests that U0126 is upstream of ROS generation.
Next, we examined ATP production, the mitochondrial membrane potential, intracellular levels of glutathione (GSH) in ESA-treated cells with or without inhibitors. ATP was decreased in ESA-treated cells in a dose-dependent manner, which was rescued by Nec1, U0126 and Toc (Figure 2d Epicatechin (μg/ml) Toc (μg/ml) Toc-Ac (μg/ml) Tocotrienol (μg/ml) RIP1 regulates ESA-mediated apoptosis via ERK pathways S Obitsu et al reduced the intracellular GSH level, which was rescued by Nacetyl cysteine (NAC, 1 mM). BSO (50 mM) completely depleted GSH, which recovered in part by NAC (1 mM). However, GSH depletion itself did not trigger cell death ( Figure 2f ). NAC blocked ESA-mediated apoptosis. Therefore, an additional increase in GSH by NAC may contribute to block ESA-mediated apoptosis. Alternatively, the increase in the redox potential in mitochondria may be important.
Nuclear localization of both AIF and ERK is necessary for ESA-mediated apoptosis. As we reported, 27 AIF has an important role in ESA-mediated apoptosis. Confocal microscopic studies revealed that DNA cleavage occurred near AIF proteins (Figure 3a) . Illustration shows that TUNEL staining (red) overlapped with AIF staining (green). The nuclear localization of AIF was seen in FBD-102b cells and rat neurons (Figure 3b) . ESA induced the partial cleavage and the release of AIF into cytosolic fraction mainly as a fulllength form. In addition, mitochondrial matrix proteins, complex Va-subunit (COX Va) and manganese superoxide dismutase (Mn-SOD) were also released to the cytoplasm upon ESA stimulation ( Figure 3c ). Next we investigated whether AIF itself triggered ESA-mediated apoptosis. Deletion mutant DN102-AIF tagged with GFP (DN102-AIF-GFP), which lacks 102 amino acids at the N-terminus of AIF, was constructed to be expressed in the nucleus without stimulation. DN102-AIF-GFP did not induce cell death although the AIF was localized in the nucleus (Figure 3d ). Cyclophilin A (cyp-A) was reported to participate in AIF translocation to the nucleus. 33 Therefore, the involvement of cyp-A was investigated in ESA-mediated apoptosis. Knockdown of cyp-A did not block ESA-mediated apoptosis despite the colocalization of AIF and cyp-A in the nucleus (Figure 3e ). AIF is reported to have an important role in programmed necrosis by interacting with histone H2AX. 4 Since we reported that histone H2AX was not phosphorylated upon ESA stimulation, we examined another molecule other than cyp-A and histone H2AX. The complete inhibition of ESA-mediated apoptosis by U0126 suggests the importance of the MEK/ERK signaling pathway. 27 We examined whether ERK activation is required for AIF-dependent cell death by ESA. An agonist of MEK/ERK pathway, 4-hydroxytamoxifen (4-HT) failed to induce cell death in DN102-AIF-transfected cells. Thus, to localize ERK in the nucleus together with AIF, PC12 cells were treated with leptomycin B (Lep-B). The viability of cells transfected with DN102-AIF was significantly decreased as compared with that of cells transfected with GFP when transfection was performed by the lipofection method. A similar result was obtained from the electroporation method, which was not significant but has a strong tendency (Figure 3f ). Although colocalization of AIF with ERK1/2 was in part in the nucleus, the presence of the two proteins in the nucleus may be important for ESA-mediated apoptosis.
Mitochondrial fission can affect apoptosis. To investigate whether ablation of mitochondrial fission inhibited or suppressed ESA-mediated apoptosis, dynamin-related protein-1 (Drp1, also known as Dnm1 or Dlp1) was knocked down by siRNA in PC12 and SH-SY5Y cells. Knockdown of rat Drp1 caused the formation of fused mitochondria (Supplementary Figure 2a) . However, ESA-mediated apoptosis was not inhibited by Drp1 knockdown, which was distributed largely in the cytosol of resting cells and appeared functional. Moreover, Drp1 knockdown in SH-SY5Y cells had no effect. In addition, an inhibitor of mitochondrial fission, Mdivi-1, did not affect cell viability (Supplementary Figures 2b and c) , suggesting that signaling pathways upstream of mitochondrial fission are important in ESA-mediated apoptosis.
RIP3 is not involved in ESA-mediated apoptosis. RIP3 as well as RIP1 is involved in TNF receptor-induced necroptosis. [8] [9] [10] At least RIP3 is essential for necroptosis. 13 Ubiquitination of RIP1 followed by its deubiquitination was initiated, and led to necroptosis upon TNF receptor stimulation in the presence of Z-VAD-fmk. 1 RIP1 ubiquitination was observed when PC12 cells were treated with TNF-a along with Z-VAD-fmk (Figure 4a ). On the other hand, ESA stimulation alone did not initiate RIP1 ubiquitination even in the presence of Z-VAD-fmk (Figures 4b and c) , suggesting no involvement of TNF-a receptor. In caspase-8-deficient SH-SY5Y cells, apoptosis was induced by ESA. This is consistent with this result. Next, we examined the involvement of RIP3 in ESA-mediated apoptosis. When Balb/c 3T3 cells were treated with TNF-a along with Z-VAD-fmk, RIP3 was associated with RIP1. Nec1 blocked the association and degradation of RIP1 and RIP3. However, RIP3 was not associated with RIP1 when PC 12 cells were treated with ESA with or without Z-VAD-fmk (Figures 4c and d) . These results indicate that ESA did not induce RIP3 activation. Figure 2 ESA triggers ROS generation in mitochondria, which is blocked by antioxidants. (a) Mitochondrial ROS and intracellular ROS were measured using fluorescent probes, MitoSOX and BeSSo-AM, respectively. Images in PC12 cells were obtained from ESA-treated cells for 5 h, and the fluorescent intensity of each image (three fields per sample were obtained) was quantified using the MetaMorph software. ROS was generated in mitochondria, which was suppressed by Toc (2 mg/ml) and U0126 (5 mM). In FBD-102b cells, the time course of fluorescent intensity was investigated. Data were obtained from two independent experiments. (b) Toc and tocotrienol blocked ESA (2 mg/ ml) apoptosis at a concentration of 0.2 mg/ml or below, whereas 20 mg/ml Toc-Ac was needed to prevent ESA-mediated apoptosis. Methyl ester of ESA (ESA-Me) did not induce cell death. (c) Antioxidants blocked ESA-mediated apoptosis. BHT, EGCG, GSP, Quercetin, sesamine, sesaminol and NAC were tested. BHT blocked ESA-mediated apoptosis at a physiological concentration (12.5 mM). For other antioxidants, higher concentrations were needed to prevent ESA-mediated apoptosis (50 mM). Data were obtained from at least two independent experiments in triplicates. Values are the means ± S.D. (n ¼ 6, 9; *Po0.05 to ESA-treated cells). (d) ATP level was decreased in a dose-dependent manner upon ESA (2 mg/ml) stimulation. Nec1 (50 mM), U0126 (5 mM) and Toc (2 mg/ml) recovered the decrease in ATP level in ESA-treated cells. ATP levels were measured 5 h after ESA stimulation (left and middle panels). ATP depletion was time-dependent, and the reduction in ATP occurred 4 h after ESA stimulation (right panel). (e) Mitochondrial membrane potential was decreased to 50% as compared with control (time ¼ 0 min) upon ESA stimulation. The potential did not disappear until the final stage of cell death. CCCP (50 mM) disappeared the potential. (f) Intracellular GSH levels were measured when cells were treated with or without BSO (10 or 50 mM) and NAC (1 mM). PC12 cells were cultured in the presence of BSO for 48 h, and then ESA (2 mg/ml) was added to the cells pretreated with buffer or NAC. Cell viability and GSH levels were measured 4 h after ESA addition. ESA did not affect intracellular GSH levels. Decrease in GSH by BSO did not trigger cell death. Values are the means±S.D. *Po0.05 (n ¼ 3, 6 in d, f). 
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Caspase-8 and FADD were not associated with RIP1 (Figures 4b and 5b) . Involvement of autophagy was next examined. ESA did not induce LC3-II formation, indicating that autophagy is not involved in ESA-mediated apoptosis (Figure 4e ). Phosphorylation of ERK1/2 occurred upon ESA stimulation. 27 To better understand the role of MEK/ERK pathway, immunoprecipitaion experiments (ip) were performed using mouse monoclonal RIP1 antibody (IgG2a). ERK1/2 proteins were constitutively associated with RIP1 regardless of ESA stimulation in PC12 and FBD-102b cells. In contrast, ERK1/2 was phosphorylated by ESA. MEK2, one of the MAPKKs, was also associated with RIP1 and phosphorylated in response to ESA. However, phosphorylated ERK1/2 was not seen on the blot of RIP1-immunoprecipitated samples. Active forms of caspase-8 were not produced by ESA (Figures 5a and b) . Inhibitors of RIP1 activity, Nec1 and Nec5, but not Nec1i (inactive form of Nec1), impaired MEK1/2 phosphorylation RIP1 regulates ESA-mediated apoptosis via ERK pathways S Obitsu et al ( Figure 5c ). Taken together, ESA activates ERK pathway through MEK2, which is blocked by U0126 and Nec1. RIP1 may be involved in ERK pathway.
Decrease in AIF/RIP1 phosphorylation has an important role in ESA-mediated apoptosis. To investigate whether ESA induces RIP1 phosphorylation, we used a phosphorylated protein purification column because there is no antibody against phosphorylated RIP1. The concentration of total proteins in each cell lysate was adjusted to the same between the samples before the lysate was applied onto the column, and was confirmed by westernblotting using a b-actin antibody. We performed the study in two conditions, mild and severe. Surprisingly, in a mild condition (ESA 2 mg/ml in 10-cm dish), AIF and RIP1 were gradually dephosphorylated over several hours (Figure 6a , left panel). Phosphorylated RIP3 was not observed. In a severe condition, (ESA 3.3 mg/ml in 10-cm dish), both AIF and RIP1 were immediately dephosphorylated (Figure 6a , left panel, experiment 1). In experiment 2, some cells were Figure 6 AIF and RIP1 are dephosphorylated by ESA. (a) PC12 cells were stimulated with ESA at two different concentrations, mild and severe (2 and 3.3 mM in 10-cm dish, respectively). ESA gradually initiated dephosphorylation of both AIF and RIP1 in a time-dependent manner in the mild condition. In the severe condition, the dephosphorylation occurred rapidly (exp-1). Dephosphorylation of AIF was occurred by 5 h after ESA stimulation (exp-2). Unlike AIF, RIP1 protein was not collected due to disruption of the membrane integrity (exp-2). Toc blocked RIP1 dephosphorylation. (b) Transmission electron microscopic analysis shows formation of apoptotic bodies and disruption of mitochondrial cristae. The long flat mitochondrial cristae structure was destroyed by ESA. Mitochondrial inner and outer membranes of some mitochondria in ESA-treated cells were collapsed. Nec1 prevented the mitochondrial damage. (c) Effects of oligomycin on ESA-mediated apoptosis. Oligomycin had a synergistic effect on ESA-mediated apoptosis. Data were obtained from two independent experiments in triplicates. Values are the means±S.D. *Po0.05 (n ¼ 6).
RIP1 regulates ESA-mediated apoptosis via ERK pathways S Obitsu et al severely damaged, and the cytosolic contents were released into culture media due to the disruption of plasma membrane integrity. Thus, RIP1 protein was hardly collected from cell lysates after 5-h ESA treatment. However, mitochondrial AIF protein was detected, and the collected AIF was not phosphorylated. Even in the severe condition, Toc blocked the AIF dephosphorylation. On the other hand, Nec1 and U0126 did not block AIF dephosphorylation. Using transmission electron microscope, we next investigated the structure of mitochondria in PC12 cells treated with ESA (Figure 6b ). Mitochondria in resting cells were 1 mm long and have normal cristae structure. In ESA-treated cells, the cristae were severely damaged, and disruptions of mitochondrial inner and outer membranes were observed. This is consistent with our result demonstrating the release of Mn-SOD and COX Va into the cytoplasm. Mitochondrial disruption was blocked by Nec1. These results suggest that ESA may influence finally on the mitochondrial respiratory chain. Lipid droplets (LDs) were observed in ESA-treated cells, whereas formation of LDs was blocked by Nec1. To further examine the effect of ESA on mitochondrial electron transport system, its inhibitor was tested together with ESA. Oligomycin slightly affected the cell viability. However, oligomycin deteriorated apoptosis to 40% in the condition that the viability of ESA-treated cells decreased to 70% (Figure 6c ).
ESA activates protein phosphatases. The effect of ESA on enzymatic activity of a Ser/Thr phosphatase, calcineurin, was examined in the presence or absence of calmodulin. ESA activated enzymatic activity of calcineurin by two fold even in the absence of calmodulin (Figure 7a ). Okadaic acid, a phosphatase inhibitor, significantly suppressed ESA-mediated apoptosis (Figure 7b ). ESA may activate phosphatases including calcineurin, which resulted in dephosphorylation of RIP1.
Discussion
In this study, we describe a novel type of neuronal cell death. ESA-mediated apoptosis is regulated by AIF, ERK, RIP1 and ROS, which are key molecules of apoptosis and necroptosis. The double knockdown experiment of AIF and RIP1 suggests that they may function in the same signaling cascade. As is well known, Nec1 can inhibit TNF-a receptor-mediated necroptosis. Nec1 blocked ESA-mediated apoptosis. Interestingly, Nec1i, which is ineffective in protecting the necroptosis, also suppressed ESA-mediated apoptosis. On the other hand, RIP3 essential for necroptosis was not involved in ESAmediated apoptosis. Caspase-8 and FADD were not changed. Together, ESA-mediated apoptosis is neither necroptosis nor RIP-dependent apoptosis triggered by TNF receptor and deletion of cIAP. One of the key events in ESA-mediated apoptosis is ROS generation in mitochondria. Like Toc, U0126 blocked ROS generation. MEK/ERK pathway may function upstream of ROS generation. Antioxidants blocked ROS generation and ESA-mediated apoptosis. Among them, Toc and BHT were effective at physiological concentrations (2 and 12.5 mg/ml, respectively), both of which are known to be diffused into intracellular organelles such as mitochondria and ER. 27, 34 The decrease in ATP levels in ESA-treated cells was a time-and a dose-dependent. Nec1 recovered the decrease in ATP; however, Nec1 did not inhibit dephosphorylation of both AIF and RIP1. ERK/1/2 and Akt are also phosphorylated upon ESA stimulation. 27 In spite of ATP depletion by ESA, these kinases are phosphorylated. This means that the dephosphorylation event is specific for AIF and RIP1. Also, the dephosphorylation is not derived from ATP depletion. ESA does not affect the intracellular GSH level, indicating that ESA does not elicit oxidative stress. It is unlikely that oxidative stress disrupts phosphatases to induce nonspecifically irreversible phosphorylation.
AIF is localized to the nucleus. Mn-SOD and COX-Va, both of which are localized in the matrix of mitochondria, are released to the cytoplasm. After ESA stimulation, cells retained the mitochondrial membrane potential until the final stage of the cell death, although it was in part reduced. On the other hand, loss of the inner and outer membranes was observed in several percentages of mitochondria in ESA-treated cells. Disruption of both membranes can explain the release of matrix proteins. RIP1 regulates ESA-mediated apoptosis via ERK pathways S Obitsu et al MEK/ERK pathway appears to be involved in ESAmediated apoptosis. ESA initiates ERK1/2 phosphorylation. RIP1 constitutively associates with ERK1/2, and transiently associates with MEK2. Nec1 and Nec5, not Nec1i, blocked phosphorylation of MEK1/2. RIP1 can mediate MEK/ERK signaling cascades in a manner different from that previously published, such as dephosphorylation. The kinase activity of RIP1 does not appear to be required for JNK activation. 22, 23 The question to be answered is how ESA stimulates RIP1. Dephosphorylation of AIF and RIP1 occurs independently of ATP level in ESA-treated cells. The dephosphorylation event is likely to be upstream of RIP1. The enzymatic activity of calcineurin, a member of Ser/Thr phosphatases, is enhanced by ESA in the absence of calmodulin. Okadaic acid, a Ser/Thr phosphatase inhibitor, significantly reduces ESA-mediated apoptosis. Taken together, ESA may first acts on phosphatases to activate their enzymatic activity, resulting in dephosphorylation of RIP as well as AIF. RIP1 as well as AIF has a number of serine residues in the molecule. In RIP1, Ser14/15, Ser20 and Ser161 are related to RIP1 kinase activity. There are many other serine residues including Ser303, Ser330/331 at the C-terminus, constitutively phosphorylated. As the kinase activity of RIP1 appears not to be involved in ESA-mediated apoptosis, dephosphorylation of RIP1 may be important for ESA-mediated apoptosis rather than the phosphorylation.
MEK1/2 inhibition blocked ESA-mediated apoptosis. Together with AIF/ERK localization in the nucleus, we think that the simultaneous localization of AIF and ERK1/2 may have a significant role in ESA-mediated apoptosis. Lep-B treatment affects the cell viability more severe in DN102-AIF-transfected cells than that in GFP-transfected cells.
Mitochondrial fission and fusion can affect apoptotic cell death. During Bax/Bak-mediated apoptosis, mitochondria are fragmented by Drp1 recruitment into mitochondria. [35] [36] [37] In contrast, mitochondrial fusion protects cells from apoptosis. 38, 39 In this study, Drp1 is not involved in ESA-mediated apoptosis. A smac mimetic activates caspase-8 through the TNF-a receptor, leading to the formation of the caspase-8/ FADD/RIP1 apoptotic complex IIb and cell death.
2,40 z-VADfmk switches from apoptosis to necrosis in some cell types such as L929 and Jurkat T cells. RIP3 determines necroptosis. 9 The phosphorylation of RIP-1 and RIP3 stabilizes their complex and regulates necroptosis. 10 Here, we show that RIP1 regulates ESA-mediated apoptosis independently of caspase-8 and FADD, which is a novel type of RIP1-dependent cell death. ESA-mediated apoptosis occurs in the caspase-8-deficient line, SH-SY5Y. Mitochondrial disruption finally resulted in cell death through ROS production.
We conclude that ESA activates phosphatases such as calcineurin followed by dephosphorylation of RIP1 as well as AIF, which results in the activation of ERK signaling pathway through MEK1/2 activation. The nuclear localization of AIF and dephosphorylation are also important in ESA-mediated apoptosis. ESA finally triggers ROS generation and the decrease in ATP in mitochondria. This leads to atypical RIP1-dependent cell death (Scheme in Figure 8 ).
Immunoblotting. PC12 cells were cultured at 6 Â 10 5 cells/dish in 10-cm poly-L-lysine-coated dishes under a differentiation condition. After 24 h, cells were cultured with NGF for another 48 h. ESA was then added to cell cultures to induce apoptosis after inhibitors, U0126 or Toc, were added when appropriate. The cells were collected after 16 h of ESA treatment. Briefly, after cells were washed with Tris-buffered saline (TBS), lysates were prepared using a Triton-based lysis buffer containing protease and phosphatase inhibitors. Neurotropic factor was included in the washing buffer to avoid other types of apoptosis caused by neurotropic factor withdrawal from differentiating cells. A mitochondrial Isolation kit (Thermo Scientific, Waltham, MA, USA) was used to prepare cytosolic and mitochondrial fractions. Phosphoproteins were purified using a PhosphoProtein Purification kit and Nanosep Ultrafiltration Column (QIAGEN, Venlo, Netherlands) according to the manufacturer's protocols. Samples were prepared from differentiated PC12 cells (4.5-5.4 Â 10 5 cells per 10-cm dish). Cell lysates, subcellular fractions, and purified phosphoprotein samples were resolved by SDS-polyacrylamide gel electrophoresis on 5-20% gradient gels, and then transferred onto polyvinylidene fluoride membranes (ATTO, Japan). Membranes were incubated with primary antibodies at 4 1C overnight, and then visualized with alkaline phosphataselabeled secondary antibodies for 1 h at room temperature. Blots were visualized by an AP-conjugated substrate kit (BioRad, Hercules, CA USA). Alternatively, enhanced ECL plus (GE Healthcare, Little Chalfont, UK) was used to visualize blots after incubation of horseradish peroxidase-labeled antibodies using an LAS-4000 mini (Fujifilm, Tokyo, Japan).
Immunoprecipitation. Lysates were immunoprecipitated with appropriate antibodies, and resulting samples were probed with primary antibodies. Protein A/G-agarose was used. In addition, to reduce the influence of antibodies used in immunoprecipitation, ImmunoCruz Optima C system beads were used according to the manufacturer's protocol. Briefly, the beads (25% v/v) and 2 mg of antibody were incubated for 1.5 h at 4 1C, centrifuged at 13 000 g for 30 s), and then washed with PBS to form a beads-antibody complex. After preclearing with Optima C system beads, precleared lysates were incubated with the beadsantibody complex at 4 1C overnight. After washing, samples were resuspended in sample buffer for westernblot analysis.
Immunofluorescence. PC12 cells on poly-L-lysine-coated glass chamber slides were washed twice with DPBS containing NGF before the cells were fixed with 4% paraformaldehyde for 30 min, and then permeabilized with cold 0.2% Triton X-100 for 10 min. After blocking with 2% bovine serum albumin for 1 h, cells were incubated with primary antibodies. Cells were washed and incubated with Alexa 488-or TexasRed-labeled secondary antibodies and Hoechst 33342 (Life Technology) at room temperature for 1 h. After washing, cells were mounted with Prolong gold mounting media (Life Technology). Fluorescence microscopy was performed using an IX71 microscope (Olympus, Tokyo, Japan), confocal microscopes, LSM 5 Pascal (CarlZeiss, Oberkochen, Germany) and TCS-SP5 (Leica Microsystems, Solms, Germany) confocal microscopes.
Overexpression. The plasmid for Bcl-2 was constructed as described elsewhere. 27 Bcl-X L in pcDNA 3 was a kind gift from Haruo Okado (Tokyo Metropolitan Institute for Neuroscience). Bcl-2 and Bcl-X L were overexpressed in PC12 cells by an electroporation method (1 Â 10 6 cells/cuvette, Amaxa Nucleofector II; Lonza) according to the manufacturer's protocol (program No. U-029). Identical numbers of transfected cells were seeded onto 35-mm dishes under the differentiation condition. At 24 h after the transfection, cells were exposed to ESA for an additional 24 h. Drp-1 was overexpressed using Lipofectamine 2000 (1 Â 10 6 cells/ml, Life Technology). Cell viability was then measured by a WST-8 assay. For AIF overexpression, total RNA was extracted from PC12 cells using Sepasol RNA I Super (Nacalai, Japan) and cDNA was synthesized using Super Script III RT (Life Technology). Rat AIF was then cloned into the Xho I/EcoRI restriction site of the pAcGFP-N1 vector (TAKARA BIO Inc) using PCR primers (forward:5 0 -TCAGATCTCGAGCACCATGTTCCGGTGTGGA GGC-3 0 for wild-type and 5 0 -GAATTCCTCGAGCACCATGCTGTCACCAGAAGAG AAA-3 0 for deletion mutants of AIF lacking the first 102 amino acids (designated as DN102-AIF), reverse:5 0 -ACTGCAGAATTCGATCTTCATGAATGTTGAA-3 0 ). The construct was then used to subclone the XhoI and DraI digested fragment into the Xho I/Dra I restriction site of the pCAGGS vector. Rat AIF plasmids with or without a GFP tag were constructed and confirmed by DNA sequences. 0 -CAUUAUCUGUCUCAGUACATT -3 0 ; rat 2, 5 0 -C UGAGAACCUCGAGUGGGATT -3 0 , Sigma) and rat Cyp-A (ON-TARGET plus smart pool; Darmacon, Thermo Scientific). ON-TARGET plus siCONTROL (Darmacon, Thermo Scientific) or Negative Universal Control (Life Technology) was used as a control for nonsequence-specific effects. Transfection efficiencies were optimized using an siRNA optimization kit (Amaxa, Lonza). Transfections were performed by electroporation (Amaxa, Lonza), and identical numbers of transfected cells were seeded onto 35 mm dishes. After 24 h of incubation under the differentiation condition, cells were exposed to ESA for an additional 24 h. Cell viability was then measured using a WST-8 assay, and western blot analysis was performed to confirm protein expression.
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